1. Home
  2. VRME vs RVPH Comparison

VRME vs RVPH Comparison

Compare VRME & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.92

Market Cap

11.5M

Sector

Technology

ML Signal

HOLD

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.89

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRME
RVPH
Founded
1999
2006
Country
United States
United States
Employees
30
14
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
9.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VRME
RVPH
Price
$0.92
$0.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$1.50
$72.00
AVG Volume (30 Days)
74.4K
657.2K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$36.85
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.59
$0.17
52 Week High
$1.51
$3.11

Technical Indicators

Market Signals
Indicator
VRME
RVPH
Relative Strength Index (RSI) 54.32 48.77
Support Level $0.81 $0.44
Resistance Level $0.92 $0.99
Average True Range (ATR) 0.07 0.11
MACD 0.01 0.01
Stochastic Oscillator 75.37 64.36

Price Performance

Historical Comparison
VRME
RVPH

About VRME VerifyMe Inc.

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: